698 related articles for article (PubMed ID: 18474127)
21. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial resistance of Salmonella enterica serotype Typhi in Dakar, Senegal.
Dromigny JA; Perrier-Gros-Claude JD
Clin Infect Dis; 2003 Aug; 37(3):465-6. PubMed ID: 12884182
[No Abstract] [Full Text] [Related]
23. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistant Salmonella typhi in Rourkela, Orissa.
Das U; Bhattacharya SS
Indian J Pathol Microbiol; 2000 Apr; 43(2):135-8. PubMed ID: 11217269
[TBL] [Abstract][Full Text] [Related]
25. Typhoid fever: narrowing therapeutic options in India.
Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
[TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial resistance pattern of Salmonella typhi isolates in Kolkata, India during 1991-2001: a retrospective study.
Mandal S; Mandal MD; Pal NK
Jpn J Infect Dis; 2002 Apr; 55(2):58-9. PubMed ID: 12082312
[No Abstract] [Full Text] [Related]
28. [Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008].
Bouzenoune F; Kellab Debbih K; Boudersa F; Kouhil S; Nezzar N
Med Mal Infect; 2011 Apr; 41(4):181-5. PubMed ID: 21093188
[TBL] [Abstract][Full Text] [Related]
29. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
Mengo DM; Kariuki S; Muigai A; Revathi G
J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
[TBL] [Abstract][Full Text] [Related]
30. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
31. First report on antimicrobial resistance and molecular characterisation of Salmonella enterica serotype Typhi isolated from human specimens in Luanda, Angola.
Francisco M; Costa SS; Belas A; Ramos J; Couto I; Pomba C; Viveiros M
J Glob Antimicrob Resist; 2018 Jun; 13():246-249. PubMed ID: 29432938
[TBL] [Abstract][Full Text] [Related]
32. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
Dutta S; Sur D; Manna B; Sen B; Bhattacharya M; Bhattacharya SK; Wain J; Nair S; Clemens JD; Ochiai RL
Int J Antimicrob Agents; 2008 Apr; 31(4):387-9. PubMed ID: 18280709
[No Abstract] [Full Text] [Related]
33. Emergence of multidrug-resistant Salmonella enterica serovar typhi in Korea.
Lee K; Yong D; Yum JH; Lim YS; Kim HS; Lee BK; Chong Y
Antimicrob Agents Chemother; 2004 Nov; 48(11):4130-5. PubMed ID: 15504831
[TBL] [Abstract][Full Text] [Related]
34. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
Rahman MM; Haq JA; Morshed MA; Rahman MA
Int J Antimicrob Agents; 2005 Apr; 25(4):345-6. PubMed ID: 15784317
[No Abstract] [Full Text] [Related]
35. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi.
Jain S; Das Chugh T
J Infect Dev Ctries; 2013 Nov; 7(11):788-95. PubMed ID: 24240035
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance in Salmonella enterica serotype Typhi isolated from chronic typhoid carriers.
Pratap CB; Patel SK; Shukla VK; Tripathi SK; Singh TB; Nath G
Int J Antimicrob Agents; 2012 Sep; 40(3):279-80. PubMed ID: 22789724
[No Abstract] [Full Text] [Related]
37. Molecular characterization of multiresistant strains of Salmonella typhi from South Asia isolated in Ontario, Canada.
Harnett N; McLeod S; AuYong Y; Wan J; Alexander S; Khakhria R; Krishnan C
Can J Microbiol; 1998 Apr; 44(4):356-63. PubMed ID: 9674108
[TBL] [Abstract][Full Text] [Related]
38. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility of 128 Salmonella enterica serovar typhi and paratyphi A isolates from northern India.
Safdar A; Kaur H; Elting L; Rolston KV
Chemotherapy; 2004 Jun; 50(2):88-91. PubMed ID: 15211083
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of current patterns and predictive trends of multidrug-resistant Salmonella Typhi in Sudan.
Elshayeb AA; Ahmed AA; El Siddig MA; El Hussien AA
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):73. PubMed ID: 29137627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
